ArticlePublic health challenges2023
Achieving COVID-19 herd immunity in Bangladesh.
Article in Public health challenges, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- COVID-19 vaccination and mortality among coronary care patients with severe acute respiratory infection in Bangladesh: a prospective study (2021-2024).The Lancet regional health. Southeast Asia · 2026Article
- Combination forecasting of COVID-19 in Bangladesh: guiding public health policy through integrated time series, ML, and DL models.BMC infectious diseases · 2025Article
- High coverage and equitable distribution of COVID-19 vaccine uptake in two vulnerable areas in Bangladesh.PLOS global public health · 2025Article
- The cost of COVID-19 vaccine delivery in Bangladesh.Human vaccines & immunotherapeutics · 2024Article
- Achieving COVID-19 herd immunity in Bangladesh.Public health challenges · 2023Article
- An agent-based secure privacy-preserving decentralized protocol for sharing and managing digital health passport information during crises.PeerJ. Computer science · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Achieving herd immunity against COVID-19 through vaccination is a global target, including in lower resource settings. Despite the challenges and limitations, Bangladesh has achieved its target of vaccinating 70% of its population, with good vaccine coverage among refugees, remote population, and women. This can be attributed to the evidence-informed adaptability and collaborative approaches of the program. Yet some challenges remain, including dependence on donors and the need to ramp up vaccination among the underserved communities. This article discusses the factors contributing to the achievements of the COVID-19 vaccination program of Bangladesh and the remaining challenges that should be addressed by the government to ensure the sustainability of the program and inform future vaccination efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.